Skip to main
IVVD

Invivyd Inc (IVVD) Stock Forecast & Price Target

Invivyd Inc (IVVD) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Invivyd Inc is positioned favorably within the expanding COVID-19 vaccine market, which saw revenues of approximately $56 billion in 2022, reflecting a substantial opportunity for growth. The company's VYD2311 has received FDA approval for a pivotal Phase 3 program (REVOLUTION) that may enhance its market potential and establish its monoclonal antibodies' superiority over conventional mRNA vaccines. With innovative design features such as half-life extension technology and optimized biophysical characteristics, Invivyd aims to capture a significant share of a projected $3-4 billion global market by 2030.

Bears say

Invivyd Inc is facing significant challenges in its product efficacy, particularly highlighted by the STAMP trial results, which revealed that the activity of its candidate against the omicron variant was reduced by approximately 200-fold compared to earlier expectations. Furthermore, there are concerning trends regarding declining vaccination rates for COVID-19 and influenza, which indicate that the overall market opportunity for antibody-based treatments is shrinking, especially among vulnerable populations such as the elderly and immunocompromised individuals. These factors, combined with misleading initial modeling results, contribute to a negative outlook on the company's stock prospects and its ability to capitalize on its antibody developments.

Invivyd Inc (IVVD) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Invivyd Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Invivyd Inc (IVVD) Forecast

Analysts have given Invivyd Inc (IVVD) a Strong Buy based on their latest research and market trends.

According to 4 analysts, Invivyd Inc (IVVD) has a Strong Buy consensus rating as of Jan 1, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Invivyd Inc (IVVD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.